RINVOQ
Drug timelines are a Plus or Pro feature.
43 regulatory and trial events tracked for RINVOQ, covering 2019-08-16 to 2026-07-15. Get the full timeline:
Most recent: EMA Authorised: Rinvoq (upadacitinib) — AbbVie Deutschland GmbH & Co. KG